Ecolab Inc. vs uniQure N.V. Ordinary Shares — how do they compare? Ecolab Inc. trades at $291.99 (market cap $80.65B), while uniQure N.V. Ordinary Shares trades at $21.71 (market cap $1.45B). The key difference: Ecolab Inc. is far larger — about 55.6× uniQure N.V. Ordinary Shares's market cap, and Ecolab Inc. pays a 1.01% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ecolab Inc. for 91 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| ECL | QURE | |
|---|---|---|
Market Cap | $80.65B | $1.45B |
Volume | 847,309 | 3,323,243 |
Sector | Basic Materials | Health |
52-Week High | $308.35 | $70.59 |
52-Week Low | $245.73 | $9.03 |
Typical Hold Time | 91 Days | 0 Days |
Enterprise Value | $89.44B | $707.46M |
Dividend Yield | 1.01% | — |
Signals from Pluang's Aura AI — not financial advice
ECL trades at $285.66, up 0.48% today, with a bullish technical signal from moving averages and strong analyst support. The stock shows robust fundamentals with a 12.57% net income margin and 21.85% ROE, though its P/E of 38.62 suggests a premium valuation. Recent earnings beat expectations in Q2 2026, and the company maintains a dividend payout, with Q3 2026 results due on October 27, 2026.
The outlook is positive, driven by high-tech and digital growth segments, but risks include elevated debt from the CoolIT acquisition and cost fluctuations. Analysts project a $326.38 price target, implying significant upside, supported by institutional buying and insider purchases, though execution risks and market volatility warrant caution.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →